Research and Reviews: A Journal of Pharmacology
E-ISSN: 2230-9861
Editor Overview
rrjop maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Publisher
STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd.
E-mail:
[email protected]
Phone:
(+91)-0120- 4781-200
Mobile:
(+91)-981-007-8958
(+91)-966-7725-932
About the Journal
Research & Reviews: A Journal of Pharmacology [2229-7006(e)] is a peer-reviewed hybrid open-access journal launched in 2011 and focused on the rapid publication of fundamental research papers on all areas of Pharmacology.
Journal Particulars
✉ [email protected]
Latest Articles
Volume: 15, Issue: 01, Year: 2025
Jeril, Dipanwita Kamila, Bhargavi S, Ruhana
Keywords: Adverse drug reactions; Drug Safety; Pharmacovigilance; Patient Safety; Drug-induced issues.
Kaipa sushma, Balyam nagalakshmi
Keywords: Chat GPT, Drug Counselling, Prism Graph Pad software and Hartwig Scale, Supporting Lifestyle Modifications.
Anshul Thakur, Balwinder Singh, Seema Thakur, Vinod Kumar Gauttam
Keywords: Azadirachta indica, Quercetin, anti-microbial, Newcastle Disease, Rheumatoid Arthritis.
Mohd. Wasiullah, Piyush Yadav, Arjun Yadav
Keywords: Calotropis gigantea, traditional medicine, antimicrobial, antimalarial, antidiabetic, healing.
Mohd. Wasiullah, Piyush Yadav, Prakriti Maurya, Tasin Ansari
Keywords: Drug Discovery, Respiratory disease, Chronic obstructive pulmonary disease (COPD), Pharmacokinetic, Pharmacodynamic, Asthma treatment
Special Issues
Journal Menu
Efficacy of a Three Drug-Based Therapy for Neuroblastoma in frog
Abstract Submission Deadline : 30/11/2023
Manuscript Submission Deadline : 25/12/2023
Special Issue Description
As far as childhood tumors go, high-risk neuroblastoma (HR-NB) is still the most hazardous. The discovery of novel therapeutic modalities is of utmost significance. Recently, we combined fendiline hydrochloride, an inhibitor of several transporters involved in the multidrug resistance of cancer cells, with the traditional pharmacological approach to NB, represented by cisplatin, and found that this combination increased the ability of cisplatin to induce apoptosis. To find a new and more effective treatment for SKNBE2 xenografts in NOD-SCID mice, we co-administered acetazolamide, a carbonic anhydrase isoform IX (CAIX) inhibitor that has been shown to boost chemotherapy efficacy in a variety of cancer types. The discrepancies in the three medications rise more than twelvefold when taken together, according to our research.
Keywords
Neuroblastoma, Fendiline hydrochloride, Acetazolamide , Drug repositioning, CAIX, Non-coding
Manuscript Submission information
Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.
Participating journals:
Journal Name
Research & Reviews: A Journal of Pharmacology, Research & Reviews: A Journal of Pharmacology
Abbrivation
ISSN
Since
2011
APC
1000 $